Omaxe Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 28, 2017, inter alia, to consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company for the Financial Year ended on March 31, 2017 along with the Financial Results of last quarter, at the recommendation of the Audit Committee which will consider and review the Financial Results in its meeting scheduled to be held on the same day, prior to the Board Meeting.
Further, the Audit Committee/Board may, inter-alia, consider and recommend Dividend on 25,00,00,000 0.1% Non-Cumulative, Non-Convertible, Redeemable Preference Shares and Final Dividend on 18,29,00,540 Equity Shares, if any, for the Financial Year 2016-2017 in the same meeting.
Further, in accordance with the applicable regulations of SEBI (Prohibition of Insider Trading) Regulations, 2015, the ?Trading Window? for dealing in Equity Shares of the Company shall remain closed from May 20, 2017 till the end of business hours on May 30, 2017, that is 48 hours after the Standalone and Consolidated Audited Financial Results are submitted to the Stock Exchanges. The same has been intimated to all the Directors, KMPs and Designated Employees of the Company.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
